Tianjin Lisheng Pharmaceutical (002393) Stock Overview

Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers its products in various forms comprising tablets, soft and hard capsules, granules, dripping pills, freeze-dried powder injections, and water injections for use in various therapeutic fields, such as circulatory system, systemic anti-infection, digestive system, nervous and endocrine system, respiratory system, musculoskeletal, and genitourinary system, as well as antitumor and immune system modulation, and big health series products. The company also provides Chinese and Western medicines; biological preparations, oral liquids, and raw materials; and intermediates, diagnostic reagents, biochemical reagents, plastic bottles, and raw materials. It also exports its products. The company was founded in 1951 and is based in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Pharmaceutical Holdings Co., Ltd.